The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases, yet current therapeutic treatments are inadequate due to a complex disease pathogenesis. The plant polyphenol apigenin has been shown to have anti-inflammatory and neuroprotective properties in a number of cell and animal models; however a comprehensive assessment has not been performed in a human model of AD. Here we have used a human induced pluripotent stem cell (iPSC) model of familial and sporadic AD, in addition to healthy controls, to assess the neuroprotective activity of apigenin. The iPSC-derived AD neurons demonstrated a hyper-excitable calcium signalling phenotype, elevated levels of nitrite, increased cytotoxicity and apoptosis, reduced neurite length and increased susceptibility to inflammatory stress challenge from activated murine microglia, in comparison to control neurons. We identified that apigenin has potent anti-inflammatory properties with the ability to protect neurites and cell viability by promoting a global down-regulation of cytokine and nitric oxide (NO) release in inflammatory cells. In addition, we show that apigenin is able to protect iPSC-derived AD neurons via multiple means by reducing the frequency of spontaneous Ca 2+ signals and significantly reducing caspase-3/7 mediated apoptosis. These data demonstrate the broad neuroprotective action of apigenin against AD pathogenesis in a human disease model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
iNOS-mediated nitric oxide production and its regulation
Aktan, F. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.042 · Cited by 1,359
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Busche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206171109 · Cited by 715
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 682
Zhou, L., & Zhu, D.-Y. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.03.001 · Cited by 663
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572
Liang, Y.-C., Huang, Y.-T., Tsai, S.-H., Lin-Shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1945 · Cited by 572
Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., & Larson, E. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.045 · Cited by 529
Self-citationHensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
Ray, W. A., Stein, C. M., Daugherty, J. R., Hall, K., Arbogast, P. G., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11131-7 · Cited by 503
The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin 1.
Hirokawa, N., Sobue, K., Kanda, K., Harada, A., & Yorifuji, H. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.1.111 · Cited by 501
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 469
Presenilins and -Secretase: Structure, Function, and Role in Alzheimer Disease
De Strooper, B., Iwatsubo, T., & Wolfe, M. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006304 · Cited by 468
Neuroinflammation in Alzheimer's disease and prion disease
Eikelenboom, P., Bate, C., Van Gool, W. A., Hoozemans, J. J. M., Rozemuller, J. M., Veerhuis, R., & Williams, A. (2002) · Glia · doi:10.1002/glia.10146 · Cited by 405
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampel, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382
The dysregulation of intracellular calcium in Alzheimer disease
Supnet, C., & Bezprozvanny, I. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 323
Šišková, Z., Justus, D., Kaneko, H., Friedrichs, D., Henneberg, N., Beutel, T., Pitsch, J., Schoch, S., Becker, A., von der Kammer, H., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.024 · Cited by 320
Zhao, L., Wang, J.-L., Liu, R., Li, X.-X., Li, J.-F., & Zhang, L. (2013) · Molecules · doi:10.3390/molecules18089949 · Cited by 311
[Apolipoprotein E polymorphism and Alzheimer disease].
van der Weide, J., Steijns, L. S. W., Jl, T., Wj, N., & Klaverwijden, G. (1996) · PubMed · Cited by 297
BLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Larson, J., Lynch, G., Games, D., & Seubert, P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01698-4 · Cited by 275
Neuronal hyperactivity--A key defect in Alzheimer’s disease?
Busche, M. A., & Konnerth, A. (2015) · BioEssays · doi:10.1002/bies.201500004 · Cited by 266
Zhang, X., Wang, G., Gurley, E. C., & Zhou, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107072 · Cited by 257
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
Rezai-Zadeh, K., Ehrhart, J., Bai, Y., Sanberg, P. R., Bickford, P., Tan, J., & Shytle, R. D. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-41 · Cited by 216
Benefits from Dietary Polyphenols for Brain Aging and Alzheimer’s Disease
Rossi, L., Mazzitelli, S., Arciello, M., Capo, C. R., & Rotilio, G. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9696-7 · Cited by 215
Mullane, K., & Williams, M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 213
Wang, J.-Z., Wu, Q., Smith, A., Grundke-Iqbal, I., & Iqbal, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01090-4 · Cited by 197
Nitric oxide induces oxidative stress and apoptosis in neuronal cells
Wei, T., Chen, C., Hou, J., Xin, W., & Mori, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00078-1 · Cited by 194
Jeohn, G.-H., Kong, L.-Y., Wilson, B., Hudson, P., & Hong, J.-S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00204-x · Cited by 186
Wang, C.-N., Chi, C.-W., Lin, Y.-L., Chen, C.-F., & Shiao, Y.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006406200 · Cited by 181
Su, J. H., Deng, G., & Cotman, C. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)81703-9 · Cited by 175
Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities
Yu, J.-T., Chang, R. C.-C., & Tan, L. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.009 · Cited by 168
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Broe, G. A., Grayson, D. A., Creasey, H. M., Waite, L. M., Casey, B. J., Bennett, H. P., Brooks, W. S., & Halliday, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.11.1586 · Cited by 160
Veerhuis, R., Janssen, I., Groot, C. J. A. D., Muiswinkel, F. L. V., Hack, C. E., & Eikelenboom, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7199 · Cited by 154
Getting to NO Alzheimer’s Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
Balez, R., & Ooi, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3806157 · Cited by 150
Self-citationOxidative Stress, Perturbed Calcium Homeostasis, and Immune Dysfunction in Alzheimer's Disease
Mattson, M. P. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100978 · Cited by 143
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 137
Self-citationKang, S. S., Lee, J. Y., Choi, Y. K., Kim, G. S., & Han, B. H. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.003 · Cited by 120
Changes in Caspase Expression in Alzheimer's Disease: Comparison with Development and Aging
Shimohama, S., Tanino, H., & Fujimoto, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0344 · Cited by 107
Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons
Losi, G., Puia, G., Garzon, G., Vuono, M. C. D., & Baraldi, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.043 · Cited by 100
Żekanowski, C., Styczyńska, M., Pepłońska, B., Gabryelewicz, T., Religa, D., Ilkowski, J., Kijanowska-Haładyna, B., Kotapka-Minc, S., Mikkelsen, S., Pfeffer, A., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00384-4 · Cited by 98
Choi, A. Y., Choi, J. H., Lee, J. Y., Yoon, K., Choe, W., Ha, J., Yeo, E., & Kang, I. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.006 · Cited by 89
Chakroborty, S., Kim, J. S., Schneider, C., West, A. R., & Stutzmann, G. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4002-14.2015 · Cited by 89
Generation of microglial cells from mouse embryonic stem cells
Beutner, C., Roy, K., Linnartz, B., Napoli, I., & Neumann, H. (2010) · Nature Protocols · doi:10.1038/nprot.2010.90 · Cited by 85
Mechanism of nitric oxide‐induced apoptosis in human neuroblastoma SH‐SY5Y cells
Moriya, R., Uehara, T., & Nomura, Y. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02167-0 · Cited by 71
Distinct mechanisms underlie distinct polyphenol‐induced neuroprotection
Yazawa, K., Kihara, T., Shen, H., Shimmyo, Y., Niidome, T., & Sugimoto, H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.011 · Cited by 70
Engel, M., Do‐Ha, D., Muñoz, S. S., & Ooi, L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2265-3 · Cited by 70
Self-citationChandler, D., Woldu, A. S., Rahmadi, A., Shanmugam, K., Steiner, N., Wright, E. P., Benavente-García, O., Schulz, O., Castillo, J., & Münch, G. W. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900504 · Cited by 65
Self-citationZhang, Y. J., Xu, Y. F., Chen, X., Wang, X. C., & Wang, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.041 · Cited by 61
Steiner, N., Balez, R., Karunaweera, N., Lind, J. M., Münch, G. W., & Ooi, L. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.013 · Cited by 57
Self-citationOoi, L., Sidhu, K., Poljak, A., Sutherland, G. T., O’Connor, M. D., Sachdev, P. S., & Münch, G. W. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0839-2 · Cited by 49
Self-citationGunawardena, D., Shanmugam, K., Low, M., Bennett, L. E., Govindaraghavan, S., Head, R. J., Ooi, L., & Münch, G. W. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0531-9 · Cited by 48
Self-citationAlzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells
Wojda, U., & Kuźnicki, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121984 · Cited by 40
Chung, H. C. Y., Lin, R. C. Y., Logan, G. J., Alexander, I. E., Sachdev, P. S., & Sidhu, K. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0440 · Cited by 24
Self-citationSteele, M. L., Truong, J., Govindaraghavan, S., Ooi, L., Sucher, N. J., & Münch, G. W. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.018 · Cited by 22
Self-citationAlzheimer's disease models and functional genomics—How many needles are there in the haystack?
Götz, J., Matamales, M., Götz, N. N., Ittner, L. M., & Eckert, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00320 · Cited by 19
Modeling Neurological Disorders by Human Induced Pluripotent Stem Cells
Kunkanjanawan, T., Noisa, P., & Parnpai, R. (2011) · BioMed Research International · doi:10.1155/2011/350131 · Cited by 15
Lie, K. H., Chung, H. C. Y., & Sidhu, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-794-1_15 · Cited by 15
Self-citation
Cited by
The Therapeutic Potential of Apigenin
Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061305 · Cited by 1,238
Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
Targa Dias Anastacio, H., Matosin, N., & Ooi, L. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02024-7 · Cited by 401
Self-citationMitochondria as central regulators of neural stem cell fate and cognitive function
Khacho, M., Harris, R., & Slack, R. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0091-3 · Cited by 399
Zhao, J., Fu, Y., Yamazaki, Y., Ren, Y., Davis, M. D., Liu, C.-C., Lu, W., Wang, X., Chen, K., Cherukuri, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19264-0 · Cited by 374
Metadata
- Authors
- Balez, R., Steiner, N., Engel, M., Muñoz, S. S., Lum, J. S., Wu, Y., Wang, D., Vallotton, P., Sachdev, P., O’Connor, M., Sidhu, K., Münch, G., & Ooi, L.
- Venue
- Scientific Reports
- Published
- 2016-08-12
- Volume
- 6
- Issue
- 1
- Pages
- 31450-31450
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2515262002
- Cited by
- 278
- References
- 71
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.